Vermillion Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$116K Sell
321
-30
-9% -$10.3K 0.03% 345
2026
Q1
$124K Buy
351
+31
+10% +$11.1K 0.05% 128
2025
Q4
$105K Buy
320
+1
+0.3% +$317 0.04% 137
2025
Q3
$90.1K Hold
319
0.02% 443
2025
Q2
$88.9K Buy
319
+1
+0.3% +$283 0.04% 136
2025
Q1
$99.1K Sell
318
-8
-2% -$2.36K 0.03% 348
2024
Q4
$84.8K Buy
+326
New +$96.7K 0.04% 136

Other funds holding AMGN

Vermillion Wealth Management's AMGN Position: Q2 2026 in Review

Vermillion Wealth Management reduced its Amgen (AMGN) stake by 8.5% in Q2 2026, selling an estimated $10.3K and leaving 321 shares worth $116K. The position accounts for 0.03% of the portfolio, ranked #345.

Vermillion Wealth Management first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $124K in Q1 2026. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Vermillion Wealth Management held 321 shares of Amgen worth $116K as of Q2 2026.
  • Vermillion Wealth Management sold 30 Amgen shares in Q2 2026, an estimated $10.3K.
  • Amgen made up 0.03% of Vermillion Wealth Management's portfolio in Q2 2026, its #345 holding.
  • Vermillion Wealth Management first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • Vermillion Wealth Management's Amgen position peaked at $124K in Q1 2026.
  • 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.